Investment analysts at William Blair upped their FY2024 EPS estimates for Kezar Life Sciences in a note issued to investors on Wednesday, November 13th. William Blair analyst M. Phipps now expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback